trb_welcome.jpg

 

The mission of TRB Chemedica Group is to develop innovative and patented pharmaceutical products and medical devices in niche therapeutic areas: rheumatology, ophthalmology and neurology.


Video on Dry Eyeeye_pic.jpg

In recent years the nosology of Dry Eye has greatly changed. Professor Baudouin, MD, PhD from National Ophthalmologiy Hospital XV-XX, Vision Institute of Paris explains through this didactic video the complexity of the Dry Eye disease. Moving beyond the simple name of Dry Eye syndrome, we now consider the condition to be Dry Eye disease, insisting on the lack of tears, the lacrimal inflammation and hyperevaporation leading to self-sustaining loops of neurogenic and palpebral inflammations.

View the video


logo-viscosealpetit.jpg

NEW! VISCOSEAL® is now available in a pre-filled syringe presentation.

Synovial Fluid Replacement after Arthroscopy

VISCOSEAL® is a viscoelastic solution containing hyaluronic acid. This solution has viscoelastic properties that are very close to those of normal synovial fluid.

VISCOSEAL® is indicated as a synovial fluid replacement after arthroscopy. In clinical trials, it has been shown to relieve post-arthroscopic symptoms such as pain, swelling and impaired joint mobility, and to promote joint recovery.

VISCOSEAL® is administered into the joint cavity at the end of the arthroscopic procedure.

VISCOSEAL® is designed to aid recovery after arthroscopy

 

Packshot_Viscoseal_petit.jpg
pdf VISCOSEAL® SYRINGE instructions for use
pdf VISCOSEAL® SYRINGE brochure

trb_lock.gif Doctor information
Distributors

trb_contact.gif Contacts

News-Events
 
 
  • English